Biogen (BIIB) Stock Price & Financial Analysis
Biogen Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Biogen
What is the current stock price for BIIB?
As of the latest trading session, BIIB stock trades at $177.34. The 52-week range is $110.04–$202.41, with a day range of $176.39–$182.23.
What is the P/E ratio for BIIB?
Biogen's trailing P/E ratio is 20.9, meaning investors pay $20.9 for every $1 of annual earnings. The forward P/E is 26.3, reflecting analyst expectations for future earnings. Biogen operates in the Healthcare sector.
Does BIIB pay dividends?
Biogen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BIIB?
Based on 34 analysts, the consensus for BIIB is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of BIIB?
Biogen's market capitalization is $26.09B, classifying it as a large-cap company. Biogen operates in the Healthcare sector within the Drug Manufacturers - General industry.